Drug Safety Matters
Un podcast de Uppsala Monitoring Centre
52 Épisodes
-
#35 Veterinary pharmacovigilance part 2 – James Mount
Publié: 28/01/2025 -
#34 Veterinary pharmacovigilance, Part I – James Mount
Publié: 17/12/2024 -
#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias
Publié: 29/11/2024 -
#32 Pharmacovigilance in older adults – Giovanni Furlan
Publié: 25/10/2024 -
#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori
Publié: 30/09/2024 -
Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects
Publié: 26/08/2024 -
Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance
Publié: 27/06/2024 -
#30 Preventing and reporting medication errors – Rabat CC & UMC
Publié: 15/05/2024 -
#29 When medicines change our behaviour – Michele Fusaroli
Publié: 23/04/2024 -
#28 Catching black swans – François Montastruc
Publié: 29/02/2024 -
#27 When drugs damage the liver – Rita Baião
Publié: 01/02/2024 -
#26 What's trending in pharmacovigilance? – Angela Caro
Publié: 20/12/2023 -
#25 A week in the name of medicines safety – part 2
Publié: 13/11/2023 -
#24 A week in the name of medicines safety – part 1
Publié: 02/11/2023 -
Uppsala Reports Long Reads – The colour of signals
Publié: 29/09/2023 -
Uppsala Reports Long Reads – Empowering patients as partners
Publié: 05/09/2023 -
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Publié: 27/06/2023 -
#22 Reforming pharmacovigilance education – Michael Reumerman
Publié: 08/05/2023 -
#21 Unlocking the power of real-world data – Patrick Ryan
Publié: 30/03/2023 -
#20 The evidence for signals – Daniele Sartori
Publié: 23/02/2023
Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.
